Europe High Potency Active Pharmaceutical Ingredient Market Report 2016

November 2016 | 102 pages | ID: E12C16F8466EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of High Potency Active Pharmaceutical Ingredient

Revenue, means the sales value of High Potency Active Pharmaceutical Ingredient

This report studies sales (consumption) of High Potency Active Pharmaceutical Ingredient in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Alkermes
• Cambex
• Dr. Reddy’s Labotatories
• Lonza Group
• Novasep
• Sandoz

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of High Potency Active Pharmaceutical Ingredient in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Synthetic
• Biotech
• Type III

Split by application, this report focuses on sales, market share and growth rate of High Potency Active Pharmaceutical Ingredient in each application, can be divided into

• Oncology
• Hormonal disorders
• Glaucoma
• Others

Contents

Europe High Potency Active Pharmaceutical Ingredient Market Report 2016

1 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT OVERVIEW

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredient
1.2 Classification of High Potency Active Pharmaceutical Ingredient
  1.2.1 Synthetic
  1.2.2 Biotech
  1.2.3 Type III
1.3 Application of High Potency Active Pharmaceutical Ingredient
  1.3.1 Oncology
  1.3.2 Hormonal disorders
  1.3.3 Glaucoma
  1.3.4 Others
1.4 High Potency Active Pharmaceutical Ingredient Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of High Potency Active Pharmaceutical Ingredient (2011-2021)
  1.5.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)
  1.5.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)

2 EUROPE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe High Potency Active Pharmaceutical Ingredient Market Competition by Manufacturers
  2.1.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe High Potency Active Pharmaceutical Ingredient (Volume and Value) by Type
  2.2.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)
  2.2.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)
2.3 Europe High Potency Active Pharmaceutical Ingredient (Volume and Value) by Countries
  2.3.1 Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Countries (2011-2016)
2.4 Europe High Potency Active Pharmaceutical Ingredient (Volume) by Application

3 GERMANY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

3.1 Germany High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  3.1.1 Germany High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  3.1.2 Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  3.1.3 Germany High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
3.2 Germany High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
3.3 Germany High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
3.4 Germany High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

4 FRANCE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

4.1 France High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  4.1.1 France High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  4.1.2 France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  4.1.4 France High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
4.2 France High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
4.3 France High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
4.4 France High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

5 UK HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

5.1 UK High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  5.1.1 UK High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  5.1.2 UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  5.1.5 UK High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
5.2 UK High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
5.3 UK High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
5.4 UK High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

6 RUSSIA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

6.1 Russia High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  6.1.1 Russia High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  6.1.2 Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  6.1.6 Russia High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
6.2 Russia High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
6.3 Russia High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
6.4 Russia High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

7 ITALY HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

7.1 Italy High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  7.1.1 Italy High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  7.1.2 Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  7.1.7 Italy High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
7.2 Italy High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
7.3 Italy High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
7.4 Italy High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

8 SPAIN HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

8.1 Spain High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  8.1.1 Spain High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  8.1.2 Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  8.1.8 Spain High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
8.2 Spain High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
8.3 Spain High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
8.4 Spain High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

9 BENELUX HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux High Potency Active Pharmaceutical Ingredient Sales and Value (2011-2016)
  9.1.1 Benelux High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
  9.1.2 Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
9.2 Benelux High Potency Active Pharmaceutical Ingredient Sales and Market Share by Manufacturers
9.3 Benelux High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type
9.4 Benelux High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application

10 EUROPE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURERS ANALYSIS

10.1 Alkermes
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Cambex
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Dr. Reddy’s Labotatories
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Lonza Group
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Novasep
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Sandoz
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 High Potency Active Pharmaceutical Ingredient Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview

11 HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURING COST ANALYSIS

11.1 High Potency Active Pharmaceutical Ingredient Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENT MARKET FORECAST (2016-2021)

14.1 Germany High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.2 France High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.3 UK High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.4 Russia High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.5 Italy High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.6 Spain High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.7 Benelux High Potency Active Pharmaceutical Ingredient Sales Forecast (2016-2021)
14.8 Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)
14.9 Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of High Potency Active Pharmaceutical Ingredient
Table Classification of High Potency Active Pharmaceutical Ingredient
Figure Europe Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type in 2015
Figure Synthetic Picture
Figure Biotech Picture
Table Application of High Potency Active Pharmaceutical Ingredient
Figure Europe Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application in 2015
Figure Oncology Examples
Figure Hormonal disorders Examples
Figure Glaucoma Examples
Figure Others Examples
Figure Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Figure Europe High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2021)
Figure Europe High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2021)
Table Europe High Potency Active Pharmaceutical Ingredient Sales of Key Manufacturers (2015 and 2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015 and 2016)
Figure 2015 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers
Figure 2016 High Potency Active Pharmaceutical Ingredient Sales Share by Manufacturers
Table Europe High Potency Active Pharmaceutical Ingredient Revenue by Manufacturers (2015 and 2016)
Table Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table 2016 Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Manufacturers
Table Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Type (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Type (2011-2016)
Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)
Figure Europe High Potency Active Pharmaceutical Ingredient Sales Growth Rate by Type (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Type (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Type (2011-2016)
Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Type (2011-2016)
Figure Europe High Potency Active Pharmaceutical Ingredient Revenue Growth Rate by Type (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Countries (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Countries (2011-2016)
Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Countries (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Revenue and Market Share by Countries (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of High Potency Active Pharmaceutical Ingredient by Countries (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales and Market Share by Application (2011-2016)
Table Europe High Potency Active Pharmaceutical Ingredient Sales Share by Application (2011-2016)
Figure Sales Market Share of High Potency Active Pharmaceutical Ingredient by Application (2011-2016)
Figure Germany High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Germany High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Germany High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table Germany High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table Germany High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table Germany High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table Germany High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table Germany High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Figure France High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure France High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table France High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table France High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table France High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table France High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table France High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table France High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Figure UK High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure UK High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table UK High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table UK High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table UK High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table UK High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table UK High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table UK High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Figure Russia High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Russia High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Russia High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table Russia High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table Russia High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table Russia High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table Russia High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table Russia High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Figure Italy High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Italy High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Italy High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table Italy High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table Italy High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table Italy High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table Italy High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table Italy High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Figure Spain High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Spain High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Spain High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table Spain High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table Spain High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table Spain High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table Spain High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table Spain High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Figure Benelux High Potency Active Pharmaceutical Ingredient Sales and Growth Rate (2011-2016)
Figure Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate (2011-2016)
Figure Benelux High Potency Active Pharmaceutical Ingredient Sales Price Trend (2011-2016)
Table Benelux High Potency Active Pharmaceutical Ingredient Sales by Manufacturers (2015 and 2016)
Table Benelux High Potency Active Pharmaceutical Ingredient Market Share by Manufacturers (2015 and 2016)
Table Benelux High Potency Active Pharmaceutical Ingredient Sales by Type (2015 and 2016)
Table Benelux High Potency Active Pharmaceutical Ingredient Market Share by Type (2015 and 2016)
Table Benelux High Potency Active Pharmaceutical Ingredient Sales by Application (2015 and 2016)
Table Benelux High Potency Active Pharmaceutical Ingredient Market Share by Application (2015 and 2016)
Table High Potency Active Pharmaceutical Ingredient Basic Information List
Table Alkermes High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alkermes High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)
Table Cambex Basic Information List
Table Cambex High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cambex High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)
Table Dr. Reddy’s Labotatories Basic Information List
Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr. Reddy’s Labotatories High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)
Table Lonza Group Basic Information List
Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Group High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)
Table Novasep Basic Information List
Table Novasep High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novasep High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz High Potency Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz High Potency Active Pharmaceutical Ingredient Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredient
Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredient
Figure High Potency Active Pharmaceutical Ingredient Industrial Chain Analysis
Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredient Major Manufacturers in 2015
Table Major Buyers of High Potency Active Pharmaceutical Ingredient
Table Distributors/Traders List
Figure Germany High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure Germany High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Figure France High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure France High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Figure UK High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure UK High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Figure Russia High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure Russia High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Figure Italy High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure Italy High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Figure Spain High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure Spain High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux High Potency Active Pharmaceutical Ingredient Sales and Growth Rate Forecast (2016-2021)
Figure Benelux High Potency Active Pharmaceutical Ingredient Revenue and Growth Rate Forecast (2016-2021)
Table Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Type (2016-2021)
Table Europe High Potency Active Pharmaceutical Ingredient Sales Forecast by Application (2016-2021)